A Randomized, placebo-controlled pilot trial to investigate the safety and efficacy of MLC901 (NEUROAID IITM) in adults following mild or moderate traumatic brain injury

被引：0
|
作者：
Theadom, A. [1 ]
Bhattacharjee, R. [1 ]
Parmar, P. [1 ]
Feigin, V. [1 ]
机构：
[1] Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.346
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
320
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Taeeumjowi-tang in Obese Korean Adults: A Double-Blind, Randomized, and Placebo-Controlled Pilot Trial
    Park, Sunju
    Nahmkoong, Won
    Cheon, ChunHoo
    Park, Jeong-Su
    Jang, Bo-Hyoung
    Shin, Yongcheol
    Kim, Kyung-Soo
    Go, Hoyeon
    Song, Yun-Kyung
    Ko, Seong-Gyu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [32] Computerized Working Memory Training for Children with Moderate to Severe Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Trial
    Phillips, Natalie Lynette
    Mandalis, Anna
    Benson, Suzanne
    Parry, Louise
    Epps, Adrienne
    Morrow, Angie
    Lah, Suncica
    JOURNAL OF NEUROTRAUMA, 2016, 33 (23) : 2097 - 2104
  • [33] Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial
    Hee-Yeon Shin
    Ha-Ri Kim
    Geon-Ho Jahng
    Chul Jin
    Seungwon Kwon
    Seung-Yeon Cho
    Seong-Uk Park
    Woo-Sang Jung
    Sang-Kwan Moon
    Chang-Nam Ko
    Jung-Mi Park
    BMC Complementary Medicine and Therapies, 21
  • [34] A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury
    Killgore, William D. S.
    Vanuk, John R.
    Shane, Bradley R.
    Weber, Mareen
    Bajaj, Sahil
    NEUROBIOLOGY OF DISEASE, 2020, 134
  • [35] Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial
    Shin, Hee-Yeon
    Kim, Ha-Ri
    Jahng, Geon-Ho
    Jin, Chul
    Kwon, Seungwon
    Cho, Seung-Yeon
    Park, Seong-Uk
    Jung, Woo-Sang
    Moon, Sang-Kwan
    Ko, Chang-Nam
    Park, Jung-Mi
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [36] TRANEXAMIC ACID FOR PATIENTS WITH TRAUMATIC BRAIN INJURY: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
    Yutthakasemsunt, Surakrant
    Kittiwattanagul, Warawut
    Piyavechvirat, Parnumas
    Phuenpathom, Nakornchai
    Thinkhamrop, Bandit
    Lumbiganon, Pisake
    JOURNAL OF NEUROTRAUMA, 2011, 28 (06) : A55 - A55
  • [37] A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury
    Sinha, Sumit
    Raheja, Amol
    Samson, Neha
    Goyal, Keshav
    Bhoi, Sanjeev
    Selvi, Arul
    Sharma, Pushpa
    Sharma, Bhawani Shankar
    NEUROLOGY INDIA, 2017, 65 (06) : 1304 - 1311
  • [38] Tranexamic acid for patients with traumatic brain injury: A randomized, double-blinded, placebo-controlled trial
    Yutthakasemsunt S.
    Kittiwatanagul W.
    Piyavechvirat P.
    Thinkamrop B.
    Phuenpathom N.
    Lumbiganon P.
    BMC Emergency Medicine, 13 (1)
  • [39] Antisecretory factor in severe traumatic brain injury (AFISTBI): protocol for an exploratory randomized placebo-controlled trial
    Reen, Linus
    Cederberg, David
    Marklund, Niklas
    Visse, Edward
    Siesjo, Peter
    TRIALS, 2025, 26 (01)
  • [40] Efficacy and safety of purslane (Portulaca oleracea) for mild to moderate chronic hand eczema; A randomized, double-blind, placebo-controlled clinical trial
    Heydarirad, Ghazaleh
    Rastegar, Sedigheh
    Haji-Abdolvahab, Habibbolah
    Fuzimoto, Andrea
    Hunter, Jennifer
    Zare, Roghayeh
    Pasalar, Mehdi
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (03) : 401 - 410
12345